메뉴 건너뛰기




Volumn 27, Issue 16, 2009, Pages 2251-2257

A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population

Author keywords

Computer simulation; Influenza vaccine adjuvant; Older adults

Indexed keywords

INFLUENZA VACCINE;

EID: 61849122853     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.024     Document Type: Article
Times cited : (16)

References (50)
  • 1
    • 0029561403 scopus 로고
    • Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database
    • Fleming D.M., Watson J.M., Nicholas S., Smith G.E., and Swan A.V. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect 115 December (3) (1995) 581-589
    • (1995) Epidemiol Infect , vol.115 , Issue.December 3 , pp. 581-589
    • Fleming, D.M.1    Watson, J.M.2    Nicholas, S.3    Smith, G.E.4    Swan, A.V.5
  • 2
    • 0027973478 scopus 로고
    • The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial
    • Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., and Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 272 December (21) (1994) 1661-1665
    • (1994) JAMA , vol.272 , Issue.December 21 , pp. 1661-1665
    • Govaert, T.M.1    Thijs, C.T.2    Masurel, N.3    Sprenger, M.J.4    Dinant, G.J.5    Knottnerus, J.A.6
  • 3
    • 0037402224 scopus 로고    scopus 로고
    • The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
    • Nichol K.L. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21 May (16) (2003) 1769-1775
    • (2003) Vaccine , vol.21 , Issue.May 16 , pp. 1769-1775
    • Nichol, K.L.1
  • 4
    • 0027385470 scopus 로고
    • Clinical effectiveness of influenza vaccination in Manitoba
    • Fedson D.S., Wajda A., Nicol J.P., Hammond G.W., Kaiser D.L., and Roos L.L. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 270 October (16) (1993) 1956-1961
    • (1993) JAMA , vol.270 , Issue.October 16 , pp. 1956-1961
    • Fedson, D.S.1    Wajda, A.2    Nicol, J.P.3    Hammond, G.W.4    Kaiser, D.L.5    Roos, L.L.6
  • 5
    • 0032517071 scopus 로고    scopus 로고
    • Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens
    • Nichol K.L., Wuorenma J., and von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 158 September (16) (1998) 1769-1776
    • (1998) Arch Intern Med , vol.158 , Issue.September 16 , pp. 1769-1776
    • Nichol, K.L.1    Wuorenma, J.2    von Sternberg, T.3
  • 6
    • 0344983434 scopus 로고    scopus 로고
    • Influenza
    • Nicholson K.G., Wood J.M., and Zambon M. Influenza. Lancet 362 November (9397) (2003) 1733-1745
    • (2003) Lancet , vol.362 , Issue.November 9397 , pp. 1733-1745
    • Nicholson, K.G.1    Wood, J.M.2    Zambon, M.3
  • 7
    • 0035884241 scopus 로고    scopus 로고
    • Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans
    • Nordin J., Mullooly J., Poblete S., Strikas R., Petrucci R., Wei F., et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 184 September (6) (2001) 665-670
    • (2001) J Infect Dis , vol.184 , Issue.September 6 , pp. 665-670
    • Nordin, J.1    Mullooly, J.2    Poblete, S.3    Strikas, R.4    Petrucci, R.5    Wei, F.6
  • 8
    • 33644757092 scopus 로고    scopus 로고
    • Rapid licensure of a new, inactivated influenza vaccine in the United States
    • Treanor J.J., Campbell J.D., Brady R.C., Keitel W.A., Drame M., Jain V.K., and Innis B.L. Rapid licensure of a new, inactivated influenza vaccine in the United States. Hum Vaccine 1 November-December (6) (2005) 239-244
    • (2005) Hum Vaccine , vol.1 , Issue.November-December 6 , pp. 239-244
    • Treanor, J.J.1    Campbell, J.D.2    Brady, R.C.3    Keitel, W.A.4    Drame, M.5    Jain, V.K.6    Innis, B.L.7
  • 9
    • 22544459957 scopus 로고    scopus 로고
    • The unmet need in the elderly: designing new influenza vaccines for older adults
    • McElhaney J.E. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23 July (Suppl. 1) (2005) S10-25
    • (2005) Vaccine , vol.23 , Issue.July SUPPL. 1
    • McElhaney, J.E.1
  • 10
    • 0037012001 scopus 로고    scopus 로고
    • Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly
    • Murasko D.M., Bernstein E.D., Gardner E.M., Gross P., Munk G., Dran S., and Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 37 January-March (2-3) (2002) 427-439
    • (2002) Exp Gerontol , vol.37 , Issue.January-March 2-3 , pp. 427-439
    • Murasko, D.M.1    Bernstein, E.D.2    Gardner, E.M.3    Gross, P.4    Munk, G.5    Dran, S.6    Abrutyn, E.7
  • 12
    • 0032091121 scopus 로고    scopus 로고
    • Toward consistency in cost-utility analyses: using national measures to create condition-specific values
    • Gold M.R., Franks P., McCoy K.I., and Fryback D.G. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 36 June (6) (1998) 778-792
    • (1998) Med Care , vol.36 , Issue.June 6 , pp. 778-792
    • Gold, M.R.1    Franks, P.2    McCoy, K.I.3    Fryback, D.G.4
  • 13
    • 34248160167 scopus 로고    scopus 로고
    • The boomers are coming: a total cost of care model of the impact of population aging on the cost of chronic conditions in the United States
    • Garrett N., and Martini E.M. The boomers are coming: a total cost of care model of the impact of population aging on the cost of chronic conditions in the United States. Dis Manag 10 April (2) (2007) 51-60
    • (2007) Dis Manag , vol.10 , Issue.April 2 , pp. 51-60
    • Garrett, N.1    Martini, E.M.2
  • 14
    • 33846409882 scopus 로고    scopus 로고
    • The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by Major Practice Category
    • Martini E.M., Garrett N., Lindquist T., and Isham G.J. The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by Major Practice Category. Health Serv Res 42 February (1 Pt 1) (2007) 201-218
    • (2007) Health Serv Res , vol.42 , Issue.February 1 PART 1 , pp. 201-218
    • Martini, E.M.1    Garrett, N.2    Lindquist, T.3    Isham, G.J.4
  • 15
    • 3042696407 scopus 로고    scopus 로고
    • Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong
    • Yap F.H., Ho P.L., Lam K.F., Chan P.K., Cheng Y.H., and Peiris J.S. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 73 August (4) (2004) 617-623
    • (2004) J Med Virol , vol.73 , Issue.August 4 , pp. 617-623
    • Yap, F.H.1    Ho, P.L.2    Lam, K.F.3    Chan, P.K.4    Cheng, Y.H.5    Peiris, J.S.6
  • 16
    • 0035071547 scopus 로고    scopus 로고
    • Excess hospital admissions for pneumonia and influenza in persons > or = 65 years associated with influenza epidemics in three English health districts: 1987-95
    • Nguyen-Van-Tam J.S., Brockway C.R., Pearson J.C., Hayward A.C., and Fleming D.M. Excess hospital admissions for pneumonia and influenza in persons > or = 65 years associated with influenza epidemics in three English health districts: 1987-95. Epidemiol Infect 126 February (1) (2001) 71-79
    • (2001) Epidemiol Infect , vol.126 , Issue.February 1 , pp. 71-79
    • Nguyen-Van-Tam, J.S.1    Brockway, C.R.2    Pearson, J.C.3    Hayward, A.C.4    Fleming, D.M.5
  • 17
    • 31344450870 scopus 로고    scopus 로고
    • Making better influenza virus vaccines?
    • Palese P. Making better influenza virus vaccines?. Emerg Infect Dis 12 January (1) (2006) 61-65
    • (2006) Emerg Infect Dis , vol.12 , Issue.January 1 , pp. 61-65
    • Palese, P.1
  • 18
    • 34247215969 scopus 로고    scopus 로고
    • MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications
    • Baldo V., Baldovin T., Floreani A., Carraro A.M., and Trivello R. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 25 May (20) (2007) 3955-3961
    • (2007) Vaccine , vol.25 , Issue.May 20 , pp. 3955-3961
    • Baldo, V.1    Baldovin, T.2    Floreani, A.3    Carraro, A.M.4    Trivello, R.5
  • 19
    • 33750108525 scopus 로고    scopus 로고
    • Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations
    • Atmar R.L., Keitel W.A., Patel S.M., Katz J.M., She D., El Sahly H., et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 43 November (9) (2006) 1135-1142
    • (2006) Clin Infect Dis , vol.43 , Issue.November 9 , pp. 1135-1142
    • Atmar, R.L.1    Keitel, W.A.2    Patel, S.M.3    Katz, J.M.4    She, D.5    El Sahly, H.6
  • 20
    • 33748447102 scopus 로고    scopus 로고
    • Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
    • Lin J., Zhang J., Dong X., Fang H., Chen J., Su N., et al. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 368 September (9540) (2006) 991-997
    • (2006) Lancet , vol.368 , Issue.September 9540 , pp. 991-997
    • Lin, J.1    Zhang, J.2    Dong, X.3    Fang, H.4    Chen, J.5    Su, N.6
  • 21
    • 22544452446 scopus 로고    scopus 로고
    • Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy
    • Iob A., Brianti G., Zamparo E., and Gallo T. Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy. Epidemiol Infect 133 August (4) (2005) 687-693
    • (2005) Epidemiol Infect , vol.133 , Issue.August 4 , pp. 687-693
    • Iob, A.1    Brianti, G.2    Zamparo, E.3    Gallo, T.4
  • 22
    • 0035414579 scopus 로고    scopus 로고
    • Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function
    • Sambhara S., Kurichh A., Miranda R., Tumpey T., Rowe T., Renshaw M., et al. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function. Cell Immunol 211 August (2) (2001) 143-153
    • (2001) Cell Immunol , vol.211 , Issue.August 2 , pp. 143-153
    • Sambhara, S.1    Kurichh, A.2    Miranda, R.3    Tumpey, T.4    Rowe, T.5    Renshaw, M.6
  • 23
    • 4043049496 scopus 로고    scopus 로고
    • The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens
    • Fritz J.H., Brunner S., Birnstiel M.L., Buschle M., Gabain A., Mattner F., and Zauner W. The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens. Vaccine 22 September (25-26) (2004) 3274-3284
    • (2004) Vaccine , vol.22 , Issue.September 25-26 , pp. 3274-3284
    • Fritz, J.H.1    Brunner, S.2    Birnstiel, M.L.3    Buschle, M.4    Gabain, A.5    Mattner, F.6    Zauner, W.7
  • 24
    • 13944257660 scopus 로고    scopus 로고
    • Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection
    • Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., et al. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J Virol 79 March (5) (2005) 2910-2919
    • (2005) J Virol , vol.79 , Issue.March 5 , pp. 2910-2919
    • Ichinohe, T.1    Watanabe, I.2    Ito, S.3    Fujii, H.4    Moriyama, M.5    Tamura, S.6
  • 25
    • 0036729733 scopus 로고    scopus 로고
    • Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals
    • Kohut M.L., Cooper M.M., Nickolaus M.S., Russell D.R., and Cunnick J.E. Exercise and psychosocial factors modulate immunity to influenza vaccine in elderly individuals. J Gerontol A Biol Sci Med Sci 57 September (9) (2002) M557-M562
    • (2002) J Gerontol A Biol Sci Med Sci , vol.57 , Issue.September 9
    • Kohut, M.L.1    Cooper, M.M.2    Nickolaus, M.S.3    Russell, D.R.4    Cunnick, J.E.5
  • 26
    • 33646808066 scopus 로고    scopus 로고
    • Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons
    • Keitel W.A., Atmar R.L., Cate T.R., Petersen N.J., Greenberg S.B., Ruben F., and Couch R.B. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 166 May (10) (2006) 1121-1127
    • (2006) Arch Intern Med , vol.166 , Issue.May 10 , pp. 1121-1127
    • Keitel, W.A.1    Atmar, R.L.2    Cate, T.R.3    Petersen, N.J.4    Greenberg, S.B.5    Ruben, F.6    Couch, R.B.7
  • 27
    • 33845602715 scopus 로고    scopus 로고
    • No effect of a traditional Chinese medicine, Hochu-ekki-to, on antibody titer after influenza vaccination in man: a randomized, placebo-controlled, double-blind trial
    • Hamazaki K., Sawazaki S., Itomura M., Huan M., Shibahara N., Kawakita T., et al. No effect of a traditional Chinese medicine, Hochu-ekki-to, on antibody titer after influenza vaccination in man: a randomized, placebo-controlled, double-blind trial. Phytomedicine 14 January (1) (2007) 11-14
    • (2007) Phytomedicine , vol.14 , Issue.January 1 , pp. 11-14
    • Hamazaki, K.1    Sawazaki, S.2    Itomura, M.3    Huan, M.4    Shibahara, N.5    Kawakita, T.6
  • 28
    • 0034946215 scopus 로고    scopus 로고
    • Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes
    • Gill H.S., Rutherfurd K.J., and Cross M.L. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 21 July (4) (2001) 264-271
    • (2001) J Clin Immunol , vol.21 , Issue.July 4 , pp. 264-271
    • Gill, H.S.1    Rutherfurd, K.J.2    Cross, M.L.3
  • 29
    • 0035887982 scopus 로고    scopus 로고
    • Bacterial meningitis in aging adults
    • Choi C. Bacterial meningitis in aging adults. Clin Infect Dis 33 October (8) (2001) 1380-1385
    • (2001) Clin Infect Dis , vol.33 , Issue.October 8 , pp. 1380-1385
    • Choi, C.1
  • 30
    • 0141669252 scopus 로고    scopus 로고
    • Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people
    • McElhaney J.E. Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people. Conn Med 67 September (8) (2003) 469-474
    • (2003) Conn Med , vol.67 , Issue.September 8 , pp. 469-474
    • McElhaney, J.E.1
  • 31
    • 61849107128 scopus 로고    scopus 로고
    • PDR Staff (ed.) Red Book, 2007 ed. Montvale, NJ: Thompson Healthcare Inc., 2007.
    • PDR Staff (ed.) Red Book, 2007 ed. Montvale, NJ: Thompson Healthcare Inc., 2007.
  • 33
    • 61849126350 scopus 로고    scopus 로고
    • cited 2008 February 4, Available from
    • Centers for Medicare & Medicaid Services; 2008 [cited 2008 February 4]. Available from: http://www.cms.hhs.gov/.
    • (2008)
  • 34
    • 61849135467 scopus 로고    scopus 로고
    • National Compensation Survey: occupational wages in the United States, June 2006. Labor USDo ed., 2007.
    • National Compensation Survey: occupational wages in the United States, June 2006. Labor USDo ed., 2007.
  • 36
    • 0036701608 scopus 로고    scopus 로고
    • Cost-effectiveness of newer treatment strategies for influenza
    • Smith K.J., and Roberts M.S. Cost-effectiveness of newer treatment strategies for influenza. Am J Med 113 September (4) (2002) 300-307
    • (2002) Am J Med , vol.113 , Issue.September 4 , pp. 300-307
    • Smith, K.J.1    Roberts, M.S.2
  • 37
    • 0033616957 scopus 로고    scopus 로고
    • Advisory Committee on Immunization Practices, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48(April (RR-4)):1-28.
    • Advisory Committee on Immunization Practices, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48(April (RR-4)):1-28.
  • 38
    • 0033579237 scopus 로고    scopus 로고
    • Winquist AG, Fukuda K, Bridges CB, Cox NJ. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recomm Rep 1999;48(December (RR-14)):1-9.
    • Winquist AG, Fukuda K, Bridges CB, Cox NJ. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recomm Rep 1999;48(December (RR-14)):1-9.
  • 39
    • 0034603350 scopus 로고    scopus 로고
    • Influenza virus neuraminidase inhibitors
    • Gubareva L.V., Kaiser L., and Hayden F.G. Influenza virus neuraminidase inhibitors. Lancet 355 March (9206) (2000) 827-835
    • (2000) Lancet , vol.355 , Issue.March 9206 , pp. 827-835
    • Gubareva, L.V.1    Kaiser, L.2    Hayden, F.G.3
  • 40
    • 9844220300 scopus 로고    scopus 로고
    • Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group
    • Hayden F.G., Osterhaus A.D., Treanor J.J., Fleming D.M., Aoki F.Y., Nicholson K.G., et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 337 September (13) (1997) 874-880
    • (1997) N Engl J Med , vol.337 , Issue.September 13 , pp. 874-880
    • Hayden, F.G.1    Osterhaus, A.D.2    Treanor, J.J.3    Fleming, D.M.4    Aoki, F.Y.5    Nicholson, K.G.6
  • 42
    • 17744412173 scopus 로고    scopus 로고
    • Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group
    • Treanor J.J., Hayden F.G., Vrooman P.S., Barbarash R., Bettis R., Riff D., et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 283 February (8) (2000) 1016-1024
    • (2000) JAMA , vol.283 , Issue.February 8 , pp. 1016-1024
    • Treanor, J.J.1    Hayden, F.G.2    Vrooman, P.S.3    Barbarash, R.4    Bettis, R.5    Riff, D.6
  • 43
    • 0018155086 scopus 로고
    • The utility of different health states as perceived by the general public
    • Sackett D.L., and Torrance G.W. The utility of different health states as perceived by the general public. J Chronic Dis 31 11 (1978) 697-704
    • (1978) J Chronic Dis , vol.31 , Issue.11 , pp. 697-704
    • Sackett, D.L.1    Torrance, G.W.2
  • 44
    • 33748267772 scopus 로고    scopus 로고
    • Velkoff, Kimberly A. DeBarros. Bureau USC. 65+ in the United States: 2005 Current Population Reports. US Census Bureau
    • December:1-243
    • Wan He, Manisha Sengupta, Victoria A, Velkoff, Kimberly A. DeBarros. Bureau USC. 65+ in the United States: 2005 Current Population Reports. US Census Bureau, Current Population Reports. 2005;P23-209(December):1-243.
    • (2005) Current Population Reports
    • He, W.1    Manisha Sengupta, V.A.2
  • 45
    • 0027515691 scopus 로고
    • Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial
    • Govaert T.M., Dinant G.J., Aretz K., Masurel N., Sprenger M.J., and Knottnerus J.A. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ 307 October (6910) (1993) 988-990
    • (1993) BMJ , vol.307 , Issue.October 6910 , pp. 988-990
    • Govaert, T.M.1    Dinant, G.J.2    Aretz, K.3    Masurel, N.4    Sprenger, M.J.5    Knottnerus, J.A.6
  • 47
    • 61849137857 scopus 로고    scopus 로고
    • Hetzel L, Smith A. The 65 Years and Over Population: 2000. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau; October 2001.
    • Hetzel L, Smith A. The 65 Years and Over Population: 2000. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau; October 2001.
  • 48
    • 61849154258 scopus 로고    scopus 로고
    • Wilmoth JR, Shkolnikov V. Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). Available at www.mortality.org or www.humanmortality.de (data downloaded on 21 January 2008).
    • Wilmoth JR, Shkolnikov V. Human Mortality Database. University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). Available at www.mortality.org or www.humanmortality.de (data downloaded on 21 January 2008).
  • 49
    • 61849105541 scopus 로고    scopus 로고
    • U.S. Department of Health and Human Services, National Center for Health Statistics, U.S. Dept. of Health and Human Services, National Center for Health Statistics, Hyattsville, MD
    • U.S. Department of Health and Human Services, National Center for Health Statistics. National Health Interview Survey, 1997-2006. U.S. Dept. of Health and Human Services, National Center for Health Statistics, Hyattsville, MD, 2007.
    • (2007) National Health Interview Survey, 1997-2006
  • 50
    • 0035879596 scopus 로고    scopus 로고
    • Influenza vaccine effectiveness among elderly nursing home residents: a cohort study
    • Monto A.S., Hornbuckle K., and Ohmit S.E. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol 154 July (2) (2001) 155-160
    • (2001) Am J Epidemiol , vol.154 , Issue.July 2 , pp. 155-160
    • Monto, A.S.1    Hornbuckle, K.2    Ohmit, S.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.